QbTest ADHD Results Example and Score Breakdown

The QbTest is a computerized continuous performance test that measures attention, impulsivity, and physical movement during a roughly 15- to 20-minute task, producing a report that compares your results against age- and sex-matched norms. It is one of the few objective tools cleared for use alongside standard clinical assessment in ADHD evaluations, and it has gained particular traction in the UK’s National Health Service and in Scandinavian clinics. But the report it generates can be confusing at first glance, and what the test can and cannot tell a clinician is more nuanced than many patients expect.

What Actually Happens During the Test

You sit in front of a computer screen and are shown a series of simple shapes, usually a circle or a square, one at a time. Your job is to press a button whenever you see the target shape and hold still when you see the non-target. The task is deliberately boring. It is designed to tax sustained attention over a long enough window that lapses become measurable. For children aged roughly 6 to 12, the test runs about 15 minutes; for adolescents and adults, it runs about 20 minutes.

While you respond to the shapes on screen, an infrared camera tracks a small reflective marker attached to a headband you wear. That camera records your head movement dozens of times per second, capturing not just large shifts in posture but also the micro-movements and fidgeting that characterize hyperactivity. The combination of button-press data and motion-tracking data is what sets the QbTest apart from older continuous performance tests that only record clicks.

The Three Domains in a QbTest Report

The report breaks results into three core areas. The activity domain captures movement data: how far your head traveled during the test, how much area that movement covered, and how much of the test duration you were physically active. The inattention domain looks at omission errors (targets you missed entirely), your average reaction time, and how variable your reaction times were across the session. The impulsivity domain tracks commission errors (pressing the button for a non-target shape) and, in younger children, anticipatory errors where the button press comes before the stimulus could reasonably have been processed.¹

Each domain generates a Q-score, which is a standardized number showing how far your performance sits from the average of a normative comparison group of the same age and sex. A Q-score around zero means your performance looks typical. Higher scores indicate greater deviation in the direction of ADHD-like patterns. Many reports also include a combined Total score. Think of the report as a set of bar charts: the further the bars extend past the normative line, the more your performance diverged from what is typical for someone your age.

Reaction time variability deserves a special mention because it is one of the most consistently replicated objective findings in ADHD research. People with ADHD tend not to be uniformly slow in their responses; instead, they show occasional very slow responses mixed with normal ones, creating a choppy pattern. Most researchers interpret this as reflecting momentary lapses in attention, possibly linked to intrusions of the brain’s default-mode network during a task that demands focused effort.² Recent neuroimaging work supports this idea, finding that people with ADHD show a distinct pattern of brain activation on a trial-by-trial basis: when their reaction times spike, activity in frontoparietal and attention networks differs from that of controls.³

How Accurate Is the QbTest on Its Own

This is where expectations need to be carefully managed. The QbTest is not a pass-fail diagnostic tool. Its diagnostic accuracy, when used as a standalone measure, is acceptable but not strong enough to confirm or rule out ADHD by itself. A meta-analysis pooling data from 15 studies and over 2,000 participants found that the Total Q-score had a sensitivity of about 78% and a specificity of about 70%.⁴ That means roughly one in five people with ADHD would score in the normal range, and about three in ten people without ADHD would look atypical on the test. The individual subscales fared worse: impulsivity scores, for example, had a pooled area-under-the-curve of only 0.59, barely better than chance.

An earlier study reported even wider variation, with sensitivity figures ranging from 47% to 67% and specificity from 72% to 84% depending on how the cutoffs were set and which population was tested.⁵ And in one clinical sample of adults referred for ADHD evaluation, the QbTest scores failed to distinguish between those who ultimately received a diagnosis and those who did not.⁶ The authors of that study explicitly cautioned clinicians against leaning too heavily on QbTest results in clinical populations where other conditions like anxiety, depression, or sleep problems might also impair attention and increase fidgeting.

None of this makes the QbTest useless, but it does mean the test is best understood as one data point in a broader clinical picture. If your QbTest report looks normal and you still have a lifetime of attention difficulties documented by teachers, employers, and family, a competent clinician will not use that normal score to dismiss the diagnosis. Conversely, an abnormal score in someone with no functional impairment does not prove ADHD.

What the Test Does Add to a Clinical Assessment

Where the QbTest shows its real value is in making the assessment process more efficient and giving clinicians more confidence in their decisions. A randomized controlled trial in the UK assigned children and adolescents with suspected ADHD to either standard assessment alone or standard assessment plus a QbTest report. Clinicians who had access to the QbTest report were 44% more likely to reach a diagnostic decision during the study period. They were also significantly more confident in that decision. Interestingly, access to the QbTest report roughly doubled the rate at which clinicians excluded an ADHD diagnosis, suggesting the test helps clinicians say “no” as well as “yes.”⁷

A systematic review covering the broader body of evidence reached a similar conclusion: the QbTest, when used alongside full clinical assessment, can reduce time to diagnosis and cut down on the number of clinic appointments needed to get there.⁸ Given how long ADHD assessment waiting lists have become in many countries, shaving even one or two appointments off the pathway is meaningful for families.

However, real-world rollout has produced some surprising results. A national evaluation of QbTest implementation across multiple NHS sites found that while the number of appointments per patient dropped by about 11.5%, the actual time from referral to diagnosis increased by roughly 55 days. Interviews with staff revealed they still perceived the test as making the process faster and more efficient, but the administrative data told a more complicated story, likely reflecting the challenges of embedding a new tool into existing clinical workflows.⁹ The lesson: a good tool is only as efficient as the system it is placed into.

Using the QbTest to Track Medication Effects

Beyond initial assessment, one of the most practical applications of the QbTest is monitoring how someone responds to ADHD medication. Once a baseline test is completed before treatment starts, follow-up tests can be run after medication begins. A systematic review of studies examining this use found that clinically meaningful drops in Q-scores appeared in the majority of studies when patients took ADHD medication at therapeutic doses, both compared with placebo and compared with their own pre-treatment baseline.¹⁰

The test appears to be sensitive enough to pick up the effects of stimulant medication very quickly. Evidence suggests the impact of methylphenidate can be detected on the QbTest as little as one hour after a dose is taken.¹¹ This makes it a potentially useful tool during dose-titration visits, where the goal is to find the lowest effective dose. Instead of relying entirely on subjective reports about whether a given dose “feels like it’s working,” the clinician can compare before-and-after Q-scores for a more concrete picture.

Healthcare staff and families both tend to value this application. Qualitative data from multiple studies show that the QbTest is appreciated for dose titration, checking whether medication remains useful over time, and even improving adherence, because patients can see concrete changes on their report rather than relying solely on how they feel.¹² That said, the evidence base for medication monitoring specifically is still catching up to the evidence for initial assessment. A recent commentary noted that more rigorous clinical trials and longitudinal studies are needed before the QbTest can be considered fully validated for treatment-response tracking.¹³

When the Numbers and the Rating Scales Do Not Match

One of the most confusing situations for patients and families is when the QbTest report and the behavioral rating scales filled out by parents or teachers point in different directions. This happens more often than you might think. Research examining how well QbTest scores line up with parent and teacher questionnaires has found inconsistent agreement, particularly for concurrent validity, meaning the two methods do not always flag the same individuals as impaired at the same time.¹⁴

There are good reasons for this. The QbTest captures a 15- to 20-minute window of performance in a quiet clinical setting. Rating scales capture months of observed behavior across classrooms, playgrounds, and home life. Someone who struggles most with sustained attention over hours of schoolwork might perform adequately during a brief, novel computer task. Conversely, someone who tests poorly might be managing fine in daily life with accommodations they have built up over years. The discrepancy itself can be informative: it tells the clinician something about the conditions under which symptoms appear.

A particularly interesting wrinkle showed up in a study comparing objective motion data with questionnaire-based hyperactivity scores. Researchers expected that children with difficulties in response inhibition (the impulsive/hyperactive profile) would show the most physical movement on the QbTest. Instead, only the group with primarily inattentive difficulties showed significantly raised activity measurements during the test. Both groups, however, scored high on behavioral rating scales for hyperactivity.¹⁵ Findings like this are a reminder that “hyperactivity” as measured by a camera and “hyperactivity” as reported by a teacher may be capturing overlapping but distinct aspects of behavior.

Taking the Test Outside the Clinic

Not everyone can easily get to a clinic, and the rise of telehealth has pushed developers to create versions of the test that can be completed at home. QbCheck is a web-based adaptation that drops the motion-tracking camera and relies on the computer’s built-in webcam to estimate movement. In a validation study, the five key QbCheck variables correctly classified about 81% of participants, with a sensitivity of roughly 83% and specificity of about 80%.¹⁶ Those numbers are close enough to the clinic-based version to make QbCheck a viable option for remote assessments, though the less controlled testing environment introduces more variability: a dog barking, a sibling walking in, or a slow internet connection can all affect results.

An even newer version, QbMobile, works on a smartphone. Instead of the infrared headband, the phone’s front-facing camera tracks facial movement while the user taps the screen in response to stimuli. An initial study found that people with ADHD scored significantly higher than a normative group (a mean Total Score of 83 versus about 49), with overall sensitivity of 0.86 and specificity of 0.75. The researchers noted a caveat for younger children: specificity was lower in that group, likely because high baseline activity levels in young children make it harder to distinguish ADHD-related movement from normal childhood fidgeting.¹⁷

What Patients and Families Actually Think

The patient experience of the QbTest is a mixed picture, and the gap between clinician enthusiasm and family understanding is worth knowing about. In a multi-methods study, clinicians were broadly positive: they valued the test for giving them something concrete and visual to point to when discussing a diagnosis. Families also generally found the test useful. But less than half of the families surveyed felt the QbTest helped them understand the clinician’s reasoning around diagnosis or medication decisions.¹⁸

That finding is striking. The report is full of graphs and standardized scores, and clinicians may assume the visual format speaks for itself. But without careful explanation, many families walk away unsure what the numbers actually mean for their child’s day-to-day life. The test can also feel reductive: parents who have spent years observing their child’s struggles may feel that a 15-minute computer task does not capture the full reality. Clinicians who use the QbTest most effectively tend to be those who spend time walking through the report in plain language, connecting the Q-scores back to the specific behaviors the family has described, and explicitly stating that the test is one piece of a larger evaluation.

One area where the QbTest does seem to help communication is between clinicians and schools. Because the report is visual and standardized, it can serve as a common reference point in conversations about classroom accommodations, providing something more concrete than subjective descriptions alone. Families who found this bridge useful tended to rate the overall experience more positively.

Conditions That Can Mimic ADHD on the Test

A normal QbTest does not rule out ADHD, and an abnormal QbTest does not rule it in, partly because several other conditions can produce similar performance profiles. Anxiety often increases restlessness and impairs concentration. Poor sleep, whether from insomnia, obstructive sleep apnea, or simply inconsistent bedtimes in children, directly affects sustained attention and reaction time variability. Depression can slow processing speed and reduce motivation to engage with a tedious task. Even caffeine intake or the timing of a missed meal can shift scores.

This is the fundamental limitation of any objective attention test: it measures performance, not the cause of that performance. Two people can produce identical Q-scores for entirely different reasons. That is why every set of clinical guidelines and every manufacturer recommendation emphasizes that the QbTest should supplement, not replace, a thorough clinical interview, developmental history, and collateral information from people who know the patient across settings. The test gives clinicians one more high-quality data point. Treated as a standalone diagnostic, it simply is not accurate enough to bear that weight.

For people going through the assessment process, the practical takeaway is straightforward: if you are asked to do a QbTest, treat it as one component of a broader evaluation. If possible, take the test when you are reasonably rested, at a consistent time of day, and, if you are already on medication, discuss with your clinician whether to test on or off medication depending on the question being asked. A test done on a night of three hours’ sleep after four cups of coffee is measuring your sleep deprivation and caffeine jitters as much as anything else. The more controlled the conditions, the more useful the data will be.